BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24925024)

  • 21. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
    Riganti C; Castella B; Massaia M
    Front Immunol; 2018; 9():1246. PubMed ID: 29937767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fat story-antigen presentation by butyrophilin 3A1 to γδ T cells.
    Esser C
    Cell Mol Immunol; 2014 Jan; 11(1):5-7. PubMed ID: 24097036
    [No Abstract]   [Full Text] [Related]  

  • 23. Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells.
    Kabelitz D
    Cell Mol Immunol; 2014 Mar; 11(2):117-9. PubMed ID: 24097034
    [No Abstract]   [Full Text] [Related]  

  • 24. Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.
    Gertner-Dardenne J; Bonnafous C; Bezombes C; Capietto AH; Scaglione V; Ingoure S; Cendron D; Gross E; Lepage JF; Quillet-Mary A; Ysebaert L; Laurent G; Sicard H; Fournié JJ
    Blood; 2009 May; 113(20):4875-84. PubMed ID: 19278954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing.
    Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
    Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. γδ T Cells in Tumor Microenvironment.
    Imbert C; Olive D
    Adv Exp Med Biol; 2020; 1273():91-104. PubMed ID: 33119877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Butyrophilin3A proteins and Vγ9Vδ2 T cell activation.
    Gu S; Borowska MT; Boughter CT; Adams EJ
    Semin Cell Dev Biol; 2018 Dec; 84():65-74. PubMed ID: 29471037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.
    Salim M; Knowles TJ; Baker AT; Davey MS; Jeeves M; Sridhar P; Wilkie J; Willcox CR; Kadri H; Taher TE; Vantourout P; Hayday A; Mehellou Y; Mohammed F; Willcox BE
    ACS Chem Biol; 2017 Oct; 12(10):2631-2643. PubMed ID: 28862425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunities and challenges in development of phosphoantigens as Vγ9Vδ2 T cell agonists.
    Wiemer DF; Wiemer AJ
    Biochem Pharmacol; 2014 Jun; 89(3):301-12. PubMed ID: 24680696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells.
    Vavassori S; Kumar A; Wan GS; Ramanjaneyulu GS; Cavallari M; El Daker S; Beddoe T; Theodossis A; Williams NK; Gostick E; Price DA; Soudamini DU; Voon KK; Olivo M; Rossjohn J; Mori L; De Libero G
    Nat Immunol; 2013 Sep; 14(9):908-16. PubMed ID: 23872678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
    Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP
    Science; 2020 Feb; 367(6478):. PubMed ID: 31919129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model.
    Sicard H; Ingoure S; Luciani B; Serraz C; Fournié JJ; Bonneville M; Tiollier J; Romagné F
    J Immunol; 2005 Oct; 175(8):5471-80. PubMed ID: 16210655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
    Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human gamma delta T cells: Evolution and ligand recognition.
    Adams EJ; Gu S; Luoma AM
    Cell Immunol; 2015 Jul; 296(1):31-40. PubMed ID: 25991474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes.
    Hsiao CH; Lin X; Barney RJ; Shippy RR; Li J; Vinogradova O; Wiemer DF; Wiemer AJ
    Chem Biol; 2014 Aug; 21(8):945-54. PubMed ID: 25065532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gene expression profile of phosphoantigen-specific human γδ T lymphocytes is a blend of αβ T-cell and NK-cell signatures.
    Pont F; Familiades J; Déjean S; Fruchon S; Cendron D; Poupot M; Poupot R; L'faqihi-Olive F; Prade N; Ycart B; Fournié JJ
    Eur J Immunol; 2012 Jan; 42(1):228-40. PubMed ID: 21968650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vγ9Vδ2 T Cells Activation Through Phosphoantigens Can Be Impaired by a RHOB Rerouting in Lung Cancer.
    Laplagne C; Meddour S; Figarol S; Michelas M; Calvayrac O; Favre G; Laurent C; Fournié JJ; Cabantous S; Poupot M
    Front Immunol; 2020; 11():1396. PubMed ID: 32733462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
    Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
    Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
    Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
    Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.